CME Competitors
| CME Stock | USD 302.48 4.28 1.40% |
CME vs Bank of Nova Scotia Correlation
Very weak diversification
The correlation between CME Group and BNS is 0.49 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CME Group and BNS in the same portfolio, assuming nothing else is changed.
Moving together with CME Stock
Moving against CME Stock
| 0.86 | FDS | FactSet Research Systems Downward Rally | PairCorr |
| 0.86 | MORN | Morningstar Earnings Call Tomorrow | PairCorr |
| 0.76 | X | TMX Group Limited | PairCorr |
| 0.62 | ATHR | Aether Holdings | PairCorr |
| 0.54 | AGMH | AGM Group Holdings | PairCorr |
CME Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between CME and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of CME and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of CME Group does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CME Stock performing well and CME Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CME's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ICE | 1.14 | (0.02) | (0.02) | 0.07 | 2.18 | 2.09 | 9.59 | |||
| COIN | 2.85 | (1.16) | 0.00 | (0.36) | 0.00 | 5.19 | 21.12 | |||
| MCO | 1.14 | (0.30) | 0.00 | (0.29) | 0.00 | 1.45 | 14.49 | |||
| BMO | 0.99 | 0.16 | 0.12 | 0.26 | 1.04 | 2.12 | 6.14 | |||
| MMC | 0.94 | (0.22) | 0.00 | (0.41) | 0.00 | 1.97 | 9.33 | |||
| BAM | 1.54 | (0.15) | (0.04) | 0.00 | 2.32 | 2.43 | 9.11 | |||
| MFG | 1.29 | 0.52 | 0.29 | 0.53 | 1.14 | 3.35 | 7.66 | |||
| NDAQ | 1.16 | (0.18) | 0.00 | (0.11) | 0.00 | 2.10 | 11.68 | |||
| IBN | 0.80 | 0.02 | (0.03) | 0.13 | 1.05 | 1.76 | 7.06 | |||
| BNS | 0.76 | 0.22 | 0.14 | 0.71 | 0.85 | 1.69 | 6.23 |
Cross Equities Net Income Analysis
Compare CME Group and related stocks such as Intercontinental Exchange, Coinbase Global, and Moodys Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICE | 15.8 M | 510 M | 552 M | 254 M | 981 M | 1.3 B | 1.4 B | 2.5 B | 2 B | 1.9 B | 2.1 B | 4.1 B | 1.4 B | 2.4 B | 2.8 B | 3.3 B | 3.5 B |
| COIN | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | (30.4 M) | 322.3 M | 3.6 B | (2.6 B) | 94.9 M | 2.6 B | 3 B | 3.1 B |
| MCO | 280.1 M | 571.4 M | 690 M | 804.5 M | 988.7 M | 941.3 M | 266.6 M | 1 B | 1.3 B | 1.4 B | 1.8 B | 2.2 B | 1.4 B | 1.6 B | 2.1 B | 2.4 B | 2.5 B |
| BMO | 825 M | 4.1 B | 4.1 B | 4.3 B | 2.2 B | 1.3 B | 2.5 B | 5.2 B | 5.8 B | 5.1 B | 7.8 B | 13.5 B | 4.4 B | 7.3 B | 8.7 B | 5.2 B | 3.9 B |
| BAM | 187 M | 2 B | 1.4 B | 2.1 B | 3.1 B | 2.3 B | 1.7 B | 1.5 B | 3.6 B | 1.9 B | 382 M | 1.9 B | 1.9 B | 1.8 B | 2.2 B | 2.5 B | 1.4 B |
| NDAQ | 35 M | 387 M | 352 M | 385 M | 414 M | 428 M | 108 M | 734 M | 458 M | 774 M | 933 M | 1.2 B | 1.1 B | 1.1 B | 1.1 B | 1.8 B | 1.9 B |
| IBN | 508.5 M | 76.4 B | 96 B | 110.4 B | 122.5 B | 101.8 B | 101.9 B | 77.1 B | 42.5 B | 95.7 B | 183.8 B | 251.1 B | 340.4 B | 442.6 B | 510.3 B | 586.8 B | 616.2 B |
| BNS | 3 B | 3 B | 3 B | 3 B | 3 B | 6.1 B | 6 B | 6.1 B | 8.4 B | 6.8 B | 9.6 B | 9.9 B | 7.4 B | 7.8 B | 7.8 B | 6.1 B | 5.6 B |
CME Group and related stocks such as Intercontinental Exchange, Coinbase Global, and Moodys Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in CME Group financial statement analysis. It represents the amount of money remaining after all of CME Group operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.CME Competitive Analysis
The better you understand CME competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, CME's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across CME's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
CME Competition Performance Charts
Five steps to successful analysis of CME Competition
CME's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by CME Group in relation to its competition. CME's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of CME in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact CME's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to CME Group, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your CME position
In addition to having CME in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small & Mid Caps ETFs Thematic Idea Now
Small & Mid Caps ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small & Mid Caps ETFs theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small & Mid Caps ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out CME Correlation with its peers. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Will Financial Exchanges & Data sector continue expanding? Could CME diversify its offerings? Factors like these will boost the valuation of CME. Projected growth potential of CME fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CME data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.35 | Dividend Share 5 | Earnings Share 11.01 | Revenue Per Share | Quarterly Revenue Growth 0.083 |
CME Group's market price often diverges from its book value, the accounting figure shown on CME's balance sheet. Smart investors calculate CME's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CME's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between CME's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CME should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.